Over the past decade, pharmacogenetic testing has emerged in clinical practice to guide
selected cardiovascular therapies. The most common implementation in practice is …

Pharmacogenomic testing can be an effective tool to enhance medication safety and
efficacy. Pharmacogenomically actionable medications are widely used, and approximately …

Abstract Purpose The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based
pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a …

Purpose The increased availability of clinical pharmacogenetic (PGx) guidelines and
decreasing costs for genetic testing have slowly led to increased utilization of PGx testing in …

Introduction: Pharmacogenetics (PGx) has the potential to improve health outcomes but cost
of testing is a barrier for equitable access. Reimbursement by insurance providers may …

Abstract Background Pharmacogenomics (PGx) can provide valuable pharmacokinetic and
pharmacodynamic information for the pharmacist's assessment of drug therapy, especially …

Pharmacogenetic testing (PGT) is increasingly being used as a tool to guide clinical
decisions. This article describes the development of an outpatient, pharmacist-led …

Several healthcare organizations have developed pre-emptive pharmacogenetic testing
programs, where testing is undertaken prior to the prescription of a medicine. This review …

Pharmacogenetic (PGx) literature has shown beneficial outcomes in safety, efficacy and cost
when evidence-based gene-drug decision making is incorporated into clinical practice. PGx …

The paradigm “one drug fits all” or “one dose fits all” will soon be challenged by
pharmacogenetics research and application. Drug response—efficacy or safety—depends …